Adriamycin

In the US, Adriamycin (doxorubicin systemic) is a member of the drug class antibiotics/antineoplastics and is used to treat Acute Lymphoblastic Leukemia, Acute Myeloblastic Leukemia, Bladder Cancer, Breast Cancer, Cancer, Hodgkin's Lymphoma, Lung Cancer, Lymphoma, Multiple Myeloma, Neuroblastoma, Osteosarcoma, Ovarian Cancer, Soft Tissue Sarcoma, Stomach Cancer, Thyroid Cancer and Wilms' Tumor.

US matches:

• Adriamycin

Ingredient matches for Adriamycin

Doxorubicin

Doxorubicin is reported as an ingredient of Adriamycin in the following countries:

• New Zealand

Doxorubicin hydrochloride (a derivative of Doxorubicin) is reported as an ingredient of Adriamycin in the following countries:

• Australia


• Denmark


• Finland


• Iceland


• Norway


• Singapore


• United States

International Drug Name Search